Michael S Toss (Michael Toss)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 29

Top Topics

Breast Cancer Cells

Saccharomyces Cerevisiae

Artificial Intelligence

Endoplasmic Reticulum

Top Venues

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

British journal of cancer

Journal of clinical pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Ayat Gamal Lashen, Michael S Toss, Islam Miligy, Emma Rewcastle, Umay Kiraz, Emiel A M Janssen, Andrew R Green, Cecily M Quinn, Ian Ellis, Emad A Rakha
Nottingham prognostic x (NPx): a risk stratification tool in ER-positive HER2-negative breast cancer: a validation study. Histopathology 85 (3) (2024)
Corinne L Woodcock, Mansour A Alsaleem, Michael S Toss, Jennifer Lothion-Roy, Anna E Harris, Jennie N Jeyapalan, Nataliya Blatt, Albert Anatolyevich Rizvanov, Regina R Miftakhova, Yousif A Kariri, Srinivasan Madhusudan, Andrew R Green, Catrin Sian Rutland, Rupert G Fray, Emad A Rakha, Nigel Patrick Mongan
The role of the ALKBH5 RNA demethylase in invasive breast cancer. Discover oncology 15 (1) (2024)
Corinne L Woodcock, Mansour A Alsaleem, Michael S Toss, Jennifer Lothion-Roy, Anna E Harris, Jennie N Jeyapalan, Nataliya Blatt, Albert Anatolyevich Rizvanov, Regina R Miftakhova, Yousif A Kariri, Srinivasan Madhusudan, Andrew R Green, Catrin Sian Rutland, Rupert G Fray, Emad A Rakha, Nigel Patrick Mongan
The role of the ALKBH5 RNA demethylase in invasive breast cancer. Discover oncology 15 (1) (2024)
Ayat Gamal Lashen, Michael S Toss, Islam Miligy, Emma Rewcastle, Umay Kiraz, Emiel A M Janssen, Andrew R Green, Cecily M Quinn, Ian Ellis, Emad A Rakha
Nottingham prognostic x (NPx): a risk stratification tool in ER-positive HER2-negative breast cancer: a validation study. Histopathology (2024)
Corinne L Woodcock, Mansour A Alsaleem, Michael S Toss, Jennifer Lothion-Roy, Anna E Harris, Jennie N Jeyapalan, Nataliya Blatt, Albert Anatolyevich Rizvanov, Regina R Miftakhova, Yousif A Kariri, Srinivasan Madhusudan, Andrew R Green, Catrin Sian Rutland, Rupert G Fray, Emad A Rakha, Nigel Patrick Mongan
The role of the ALKBH5 RNA demethylase in invasive breast cancer. Discover oncology 15 (1) (2024)
Shorouk Makhlouf, Noorul Wahab, Michael S Toss, Asmaa Ibrahim, Ayat Gamal Lashen, Nehal M Atallah, Suzan Ghannam, Mostafa Jahanifar, Wenqi Lu, Simon Graham, Nigel P Mongan, Mohsin Bilal, Abhir Bhalerao, David Snead, Fayyaz Minhas, Shan E Ahmed Raza, Nasir Rajpoot, Emad Rakha
Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence. British journal of cancer (2023)
Ayat Gamal Lashen, Michael S Toss, Louisa Wootton, Andrew R Green, Nigel Patrick Mongan, Madhusudhan Srinivasan, Emad A Rakha
Characteristics and prognostic significance of polo-like kinase-1 (PLK1) expression in breast cancer. Histopathology (2023)
Ayat Gamal Lashen, Michael S Toss, Wakkas Fadhil, Georgette Oni, Srinivasan Madhusudan, Emad A Rakha
Evaluation oncotype DX ® 21-gene recurrence score and clinicopathological parameters: a single institutional experience. Histopathology (2023)
Ayat Gamal Lashen, Michael S Toss, Wakkas Fadhil, Georgette Oni, Srinivasan Madhusudan, Emad A Rakha
Evaluation oncotype DX ® 21-gene recurrence score and clinicopathological parameters: a single institutional experience. Histopathology 82 (5) (2023)
Marina Ciscar, Eva María Trinidad, Gema Perez-Chacon, Mansour A Alsaleem, Maria Jimenez, Maria J Jimenez-Santos, Hector Perez-Montoyo, Adrián Sanz-Moreno, Andrea Vethencourt, Michael S Toss, Anna Petit, Maria T Soler-Monso, Victor Lopez, Jorge Gómez-Miragaya, Clara Gomez-Aleza, Lacey Elizabeth Dobrolecki, Michael T Lewis, Alejandra Bruna, Silvana Mouron, Miguel Quintela-Fandino, Fatima Al-Shahrour, Antonio Martinez-Aranda, Angels Sierra, Andrew R Green, Emad Rakha, Eva Gonzalez Suarez
RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer. EMBO molecular medicine (2023)
Ayat Gamal Lashen, Michael S Toss, Wakkas Fadhil, Georgette Oni, Srinivasan Madhusudan, Emad A Rakha
Evaluation oncotype DX ® 21-gene recurrence score and clinicopathological parameters: a single institutional experience. Histopathology 82 (5) (2023)
Ayat Gamal Lashen, Michael S Toss, Andrew R Green, Nigel Patrick Mongan, Emad A Rakha
Ki67 assessment in invasive luminal breast cancer: a comparative study between different scoring methods. Histopathology 81 (6) (2022)
Anastasia Constantinidou, Yiola Marcou, Michael S Toss, Timothy Simmons, Ryan Bernhisel, Elisha Hughes, Braden Probst, Stephanie Meek, Eleni Kakouri, Georgios Georgiou, Ioanna Zouvani, Gabriella Savvidou, Vanessa Kuhl, Jennifer Doedt, Susanne Wagner, Alexander Gutin, Thomas P Slavin, Jerry S Lanchbury, Ralf Kronenwett, Ian O Ellis, Emad A Rakha
Clinical Validation of EndoPredict in Pre-Menopausal Women with ER-Positive, HER2-Negative Primary Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (20) (2022)
Asmaa Ibrahim, Michael S Toss, Shorouk Makhlouf, Islam M Miligy, Fayyaz Ul Amir Afsar Minhas, Emad A Rakha
Improving mitotic cell counting accuracy and efficiency using phosphohistone-H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading. Histopathology (2022)
Ayaka Katayama, Islam M Miligy, Sho Shiino, Michael S Toss, Karim Eldib, Sasagu Kurozumi, Cecily M Quinn, Nahla Badr, Ciara Murray, Elena Provenzano, Grace Callagy, Cian Martyn, Rebecca Millican-Slater, Colin Purdie, Dave Purnell, Sarah E Pinder, Tetsunari Oyama, Abeer M Shaaban, Ian O Ellis, Andrew H S Lee, Emad A Rakha
Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 34 (7) (2021)
Emad A Rakha, Michael S Toss, Cecily Quinn
Specific cell differentiation in breast cancer: a basis for histological classification. Journal of clinical pathology (2021)
Khloud A ElSharawy, Michael S Toss, Sara Raafat, Graham Roy Ball, Andrew R Green, Mohammed A Aleskandarany, Leslie W Dalton, Emad A Rakha
Prognostic significance of nucleolar assessment in invasive breast cancer. Histopathology 76 (5) (2020)
Emad A Rakha, Michael S Toss, Sho Shiino, Paul Gamble, Ronnachai Jaroensri, Craig H Mermel, Po-Hsuan Cameron Chen
Current and future applications of artificial intelligence in pathology: a clinical perspective. Journal of clinical pathology 74 (7) (2020)
Islam M Miligy, Michael S Toss, Sho Shiino, Georgette Oni, Binafsha M Syed, Hazem Khout, Qing Ting Tan, Andrew R Green, R Douglas Macmillan, John F R Robertson, Emad A Rakha
Correction: The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situ. British journal of cancer (2020)
Mansour A Alsaleem, Graham Ball, Michael S Toss, Sara Raafat, Mohammed Aleskandarany, Chitra Joseph, Angela Ogden, Shristi Bhattarai, Padmashree C G Rida, Francesca Khani, Melissa Davis, Olivier Elemento, Ritu Aneja, Ian O Ellis, Andrew R Green, Nigel Patrick Mongan, Emad Rakha
A novel prognostic two-gene signature for triple negative breast cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 33 (11) (2020)
Islam M Miligy, Michael S Toss, Sho Shiino, Georgette Oni, Binafsha M Syed, Hazem Khout, Qing Ting Tan, Andrew R Green, R Douglas Macmillan, John F R Robertson, Emad A Rakha
The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situ. British journal of cancer 123 (10) (2020)
Emad A Rakha, Mansour Alsaleem, Khloud A ElSharawy, Michael S Toss, Sara Raafat, Raluca Mihai, Fayyaz A Minhas, Andrew R Green, Nasir M Rajpoot, Leslie W Dalton, Nigel P Mongan
Visual histological assessment of morphological features reflects the underlying molecular profile in invasive breast cancer: a morphomolecular study. Histopathology 77 (4) (2020)
Michael S Toss, Islam M Miligy, Kylie L Gorringe, Mohammed A Aleskandarany, Abdulbaqi Alkawaz, Karuna Mittal, Ritu Aneja, Ian O Ellis, Andrew R Green, Emad A Rakha
Collagen (XI) alpha-1 chain is an independent prognostic factor in breast ductal carcinoma in situ. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 32 (10) (2019)
Islam M Miligy, Michael S Toss, Hazem Khout, Lisa Whisker, Helen C Burrell, Ian O Ellis, Andrew R Green, Douglas Macmillan, Emad A Rakha
Surgical management of ductal carcinoma in situ of the breast: A large retrospective study from a single institution. The breast journal 25 (6) (2019)
Michael S Toss, Islam Miligy, Kylie Gorringe, Karuna Mittal, Ritu Aneja, Ian Ellis, Andrew Green, Emad Rakha
Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ. Journal of clinical pathology 73 (2) (2019)
Mansour Alsaleem, Michael S Toss, Chitra Joseph, Mohammed Aleskandarany, Sasagu Kurozumi, Ibrahim Alshankyty, Angela Ogden, Padmashree C G Rida, Ian O Ellis, Ritu Aneja, Andrew R Green, Nigel Patrick Mongan, Emad A Rakha
The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohorts. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 32 (7) (2019)
Michael S Toss, Islam M Miligy, Rita Haj-Ahmad, Kylie L Gorringe, Abdulbaqi AlKawaz, Karuna Mittal, Ian O Ellis, Andrew R Green, Emad A Rakha
The prognostic significance of lysosomal protective protein (cathepsin A) in breast ductal carcinoma in situ. Histopathology 74 (7) (2019)
Michael S Toss, I Miligy, Abdubaqi Al-Kawaz, Mansour Alsleem, Hazem Khout, Padmashree C Rida, Ritu Aneja, Andrew R Green, Ian O Ellis, Emad A Rakha
Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 31 (8) (2018)
Sultan N Sonbul, Mohammed A Aleskandarany, Sasagu Kurozumi, Chitra Joseph, Michael S Toss, Maria Diez-Rodriguez, Christopher C Nolan, Abhik Mukherjee, Stewart Martin, Carlos Caldas, Ian O Ellis, Andrew R Green, Emad A Rakha
Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 31 (11) (2018)